New Drugs Regulating Cytoskeletons in Human Health and Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 1211
Special Issue Editors
Interests: the role of the microtubule-associated protein Tau; the impact of new chemotherapeutic molecules
Interests: medicinal chemistry
Special Issue Information
Dear Colleagues,
It is a great pleasure to invite you to contribute to the Special Issue entitled “New drugs regulating cytoskeletons in human health and diseases”. The cytoskeletons constitute so many functional networks involved in biological processes, such as cell division and mechanotransduction, motility, intracellular organelles trafficking and macromolecules, and cell morphogenesis. Given that they are a key component of eukaryotic cells, it is not surprising that they continue to represent a prime pharmacological target in human health and diseases.
Exploratory research is being conducted in many laboratories around the world, and both synthetic and natural compounds or their derivatives with therapeutic properties are being investigated. Non-primary use of known drugs is also under research.
This Special Issue welcomes original articles and reviews addressing the search for new agents and the repurposing of known drugs for the treatment of cytoskeleton-associated diseases.
Dr. Gilles Breuzard
Dr. Maxime Robin
Dr. Hervé Kovacic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- tubulin
- actine
- cytoskeletons
- associated proteins
- pharmacological agent
- repurposing of drugs
- oncology
- neurodegenerative diseases
